Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reports

BACKGROUND: Gastric and colorectal cancers remain the major causes of cancer-related death. Although chemotherapy improves the prognosis of the patients with gastrointestinal cancers, some patients do not benefit from therapy and are exposed to the adverse effects. The polymorphisms in genes includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haixia, Shi, Wei, Zhao, Lianli, Dai, Dianlu, Gao, Jinghua, Kong, Xiangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922816/
https://www.ncbi.nlm.nih.gov/pubmed/27382306
http://dx.doi.org/10.2147/OTT.S105158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922816/
https://www.ncbi.nlm.nih.gov/pubmed/27382306
http://dx.doi.org/10.2147/OTT.S105158

Ejemplares similares